Evidence map›Paper›PMID 31798903›Full record

Observational studyBMJ open diabetes research & care2019

Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.

Rianneke de Ritter, Simone J S Sep, Carla J H van der Kallen, Miranda T Schram, Annemarie Koster, Abraham A Kroon, Marleen M J van Greevenbroek, Simone J P M Eussen, Pieter C Dagnelie, Marit de Jong and 5 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open diabetes research & care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Rianneke de RitterDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.ORCID 0000-0003-2858-1874
Simone J S SepDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Carla J H van der KallenDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Miranda T SchramDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.ORCID 0000-0001-8113-7604
Annemarie KosterDepartment of Social Medicine, Maastricht University, Maastricht, The Netherlands.
Abraham A KroonDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Marleen M J van GreevenbroekDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.ORCID 0000-0002-2989-1631
Simone J P M EussenCARIM Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Pieter C DagnelieDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Marit de JongJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0001-9260-4458
Rimke C VosJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-1074-6255
Mark WoodwardThe George Institute for Global Health, University of Oxford, Oxford, United Kingdom.
Michiel L BotsJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Sanne A E PetersJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-0346-5412
Coen D A StehouwerDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Maastricht University Medical Centre · NLMaastricht University · NLUniversity Medical Center Utrecht · NLJohns Hopkins University · USLeiden University Medical Center · NLThe George Institute for Global Health · GB

Funding

Medical Research Council MR/P014550/1
6 · The paper itself

Abstract

Objective: To investigate whether adverse differences in levels of cardiovascular risk factors in women than men, already established when comparing individuals with and without diabetes, are also present before type 2 diabetes onset. Research design and methods: In a population-based cohort study of individuals aged 40-75 years (n=3410; 49% women, 29% type 2 diabetes (oversampled by design)), we estimated associations with cardiometabolic and lifestyle risk factors of (1) pre-diabetes and type 2 diabetes (reference category: normal glucose metabolism) and (2) among non-diabetic individuals, of continuous levels of hemoglobin A1c (HbA1c). Age-adjusted sex differences were analyzed using linear and logistic regression models with sex interaction terms. Results: In pre-diabetes, adverse differences in cardiometabolic risk factors were greater in women than men for systolic blood pressure (difference, 3.02 mm Hg; 95% CI:-0.26 to 6.30), high-density lipoprotein (HDL) cholesterol (difference, -0.10 mmol/L; 95% CI: -0.18 to -0.02), total-to-HDL cholesterol ratio (difference, 0.22; 95% CI: -0.01 to 0.44), triglycerides (ratio: 1.11; 95% CI: 1.01 to 1.22), and inflammation markers Z-score (ratio: 1.18; 95% CI: 0.98 to 1.41). In type 2 diabetes, these sex differences were similar in direction, and of greater magnitude. Additionally, HbA1c among non-diabetic individuals was more strongly associated with several cardiometabolic risk factors in women than men: per one per cent point increase, systolic blood pressure (difference, 3.58 mm Hg; 95% CI: -0.03 to 7.19), diastolic blood pressure (difference, 2.10 mm Hg; 95% CI: -0.02 to 4.23), HDL cholesterol (difference, -0.09 mmol/L; 95% CI: -0.19 to 0.00), and low-density lipoprotein cholesterol (difference, 0.26 mmol/L; 95% CI: 0.05 to 0.47). With regard to lifestyle risk factors, no consistent pattern was observed. Conclusion: Our results are consistent with the concept that the more adverse changes in cardiometabolic risk factors in women (than men) arise as a continuous process before the onset of type 2 diabetes.

Indexed as

Body Mass IndexLife StyleBiomarkersBlood GlucoseBlood PressureCardiovascular DiseasesCase-Control StudiesCholesterol, HDLCholesterol, LDLDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlycated HemoglobinHumansMaleMiddle AgedBiomarkersBlood GlucoseCholesterol, HDLCholesterol, LDLGlycated Hemoglobinhemoglobin A1c protein, humanTriglyceridescardiovascular risk factorspre-diabetessex differencewomen's health

Identifiers

PMID31798903
PMCPMC6861068
OpenAlexW2983007116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.